Roche Venture Fund
Roche · Corporate venture capital
UncertainLast verified 7 Nov 2026
Corporate venture capital fund of Roche investing CHF 3–10m primarily in Series A rounds of life sciences, therapeutics, diagnostics, and healthcare technology companies.
0 deals in the last 24 months. Taken from its own website.
Key facts
- Stages
- Series A
- Sectors
- Biotech & pharma, Medtech, Healthtech
- Ticket
- €3.3M–€10.9M
- Eligible countries
- Not stated
- Provider based in
- Switzerland
- Timing
- Rolling applications
- Focus
- innovative medicines; diagnostics; life science technologies; preclinical therapeutics
- How to apply
- Apply route unknown
Recent deals
No deals in our data for the last 24 months.
Evidence
Short excerpts from the sources, in their original language, that back the facts above.
- Kind
We make investments in life science companies aiming to create value by fostering innovation, guiding successful businesses and generating financial return to…
https://www.roche.com/venturefund/venturefund-investing - Sectors
We invest in private companies with innovative medicines, diagnostics and technologies.
https://www.roche.com/venturefund/venturefund-investing - Stages
We focus on Series A investments though we will invest later.
https://www.roche.com/venturefund/venturefund-investing - Ticket
In general, we will invest CHF 3-10 million in the first financing round with a 15% ownership stake
https://www.roche.com/venturefund/venturefund-investing - Ticket
In general, we will invest CHF 3-10 million in the first financing round with a 15% ownership stake
https://www.roche.com/venturefund/venturefund-investing
Status history
- 7 Nov 2026: Rolling → Uncertain (freshness: investor activity)
- 6 Nov 2026: Rolling (first extraction)
Something wrong or out of date? Report an error.
Work at Roche? Claim this profile to confirm what you invest in.